Clinical trial the effect of Hypericum Perforatum (Perforan) on wound healing episiotomy in women

The effect of Hypericum Perforatum (Perforan) on wound healing episiotomy in women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201505061557N5

Enrollment

120

Registered

2015-06-27

Start date

2014-10-07

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Episiotomy during vaginal delivery. Disruption of wound of

Interventions

Intervention 1: intervention group:Hypericum Perforatum (Perforan) ointment, Combined Vaseline with Hypericum Perforatum extracts, 25% concentration, three times daily for 10 days, POURSINA PHARMACEU

Prevention

Placebo

intervention group:Hypericum Perforatum (Perforan) ointment, Combined Vaseline with Hypericum Perforatum extracts, 25% concentration, three times daily for 10 days, POURSINA PHARMACEUTICAL COMPANY

Control group: Vaseline ointment, three times daily for 10 days, POURSINA PHARMACEUTICAL COMPANY

Eligibility

Sex/Gender

Female

Age

16 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: singleton pregnancy;primiparous; episiotomy Exclusion criteria: severe infection in 5th day after episiotomy; any acute or chronic diseases or allergy to Hypericum Perforatum

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Before intervention, 5 and 10 day after intervention. Method of measurement: visual analogue scale.;Discharge. Timepoint: Before the intervention, 5 and 10 days after the intervention. Method of measurement: Presence of suppurative vaginal discharge.;Remained sutures. Timepoint: Before the intervention, 5 and 10 days after the intervention. Method of measurement: number of remained sutures.;Dehiscence. Timepoint: 10th day after intervention. Method of measurement: Incidence of wound dehiscence.;Edema. Timepoint: Before the intervention, 5 and 10 days after the intervention. Method of measurement: Diameter of edema on wound site in Centimiter.;Redness. Timepoint: Before the intervention, 5 and 10 days after the intervention. Method of measurement: Diameter of redness in millimeter.	—

Measure

Time frame

Pain. Timepoint: Before intervention, 5 and 10 day after intervention. Method of measurement: visual analogue scale.;Discharge. Timepoint: Before the intervention, 5 and 10 days after the intervention. Method of measurement: Presence of suppurative vaginal discharge.;Remained sutures. Timepoint: Before the intervention, 5 and 10 days after the intervention. Method of measurement: number of remained sutures.;Dehiscence. Timepoint: 10th day after intervention. Method of measurement: Incidence of wound dehiscence.;Edema. Timepoint: Before the intervention, 5 and 10 days after the intervention. Method of measurement: Diameter of edema on wound site in Centimiter.;Redness. Timepoint: Before the intervention, 5 and 10 days after the intervention. Method of measurement: Diameter of redness in millimeter.

—

Secondary

Measure	Time frame
Infection. Timepoint: Before the intervention, 5 and 10 days after the intervention. Method of measurement: Presence of infective discharge and dehiscence of wound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKobra Abbasinia

Arak University of Medical Sciences

kobraabbasinya@yahoo,com+98 86 3417 3502

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026